Back to search
FDAFDA · Food and drugs·Recall number D-1330-2022

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

Published August 17, 2022 · Recall initiated: July 19, 2022

Summary

FDA records drug Class II recall D-1330-2022, published August 17, 2022 and initiated July 19, 2022. Recalling firm: Strides Pharma Inc.; Status: Terminated; Reported quantity: 1032 bottles; Lot: Lot #: 7248988B, Exp 9/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

What to do

Voluntary: Firm initiated · Letter

Get an email if PREDNISONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PREDNISONE
Manufacturer
Strides Pharma Inc.
Distributor
US Nationwide
UPC
0364380949060
Lot
Lot #: 7248988B, Exp 9/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06. recalled?

Yes. FDA published recall D-1330-2022 on August 17, 2022. Reported hazard: Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PREDNISONE. UPC: 0364380949060.